Clonidine

Objective: Menopause is associated with critical changes in the cardiovascular system, and the possible effect of hormonal replacement therapy HRT ; on these changes is under investigation. The aim of our study was to evaluate in postmenopausal women the effects of HRT and clonidine on the response of plasma calcitonin gene-related peptide CGRP ; and plasma atrial natriuretic peptide ANP ; to the upright posture test and the saline infusion test respectively. Methods: CGRP and ANP levels were measured with specific radioimmunological assays and expressed in pmol l means S.E.M ; . Design: Postmenopausal women age 4653 years ; n 18 ; were studied before and after 3 months of HRT n 13 ; or clonidine treatment n 5 ; . Results: After HRT or clonidine treatment plasma CGRP levels 149 16 and 159 38 pmol l ; were significantly higher than before 98 06 and 105 16 pmol l ; P 001 ; . The assumption of upright posture caused no change in plasma CGRP levels before treatment, while after HRT, but not after clonidine treatment, an increase in plasma CGRP levels was observed P 001 at 5 and 20 min ; . Basal plasma ANP levels significantly decreased after both HRT and clonidine treatment P 001 ; . In untreated women the saline infusion test did not induce any change in plasma ANP levels; a significant response to the test was restored after HRT but not after clonidine treatment P 001 at 90 and 120 min ; . Conclusions: The results show that some of the adaptive responses modified by menopausal changes are restored by HRT but not clonidine treatment, suggesting a modulatory role for sex steroid hormones in cardiovascular function and salt and water balance. European Journal of Endocrinology 137 664669. Guanfacine tenex ; and its half brothe clonidine catapres ; are not novel.

Necrotizing arteriolitis E ; necrotizing glomerulitis INT-7.190. Case Study: Select the correct diagnosis: the patient suddenly developed unilateral blindness, acute pancreatitis and renal failure? A ; polyarteritis nodosa B ; obstructive uropathy C ; acute tubular necrosis D ; atheroembolic renal disease E ; acute glomerulonephritis INT-7.191. Case Study: A 32-year-old male patient complains of various fits of hypertension and headaches. The repeatedly determined urine and plasma vanillylmandelic acid, catecholamine, and metanephrine values were normal. Select a possible explanation: A ; cerebral astrocytoma B ; a non-functioning adrenal tumor C ; aortic coarctation D ; aberrant adrenal tissue E ; an inadequate sampling of the urine INT-7.192. Case Study: The blood pressure of a pregnant woman 24th week of gestation ; was 170 100 mmHg. Select a possible explanation: A ; borderline or mild hypertension B ; pseudohypertension of pregnancy C ; hyperkinetic syndrome D ; severe hypertension E ; sustained hypertension INT 7.193. Which drugs or drug combinations should be avoided in the therapy of pheochromocytoma? A ; dibenzyline B ; beta-blockade followed by alpha blockade C ; alpha-blockade followed by beta blockade D ; prazosin E ; clonidine INT-7.194. Which of the following studies will yield pathological values in neurofibromatosis with hypertension? A ; the determination of the concentration of metanephrine in a 24-hour urine sample B ; the plasma renin activity C ; the serum cortisol level D ; the determination of the concentration of aldosterone in a 24hour urine sample E ; the fractional potassium excretion INT-7.195.
Geuken, E., Visser, D., Kuipers, F., Blokzijl, H., Leuvenink, H. G. D., Jong, K. P. de, Peeters, P. M. J. G., Jansen, P. L. M., Slooff, M. J. H., Gouw, A. S. H., Porte, R. J. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. Journal of Hepatology 41 6 ; : 1017-1025, 2004. Groen, H., Bij, W. van der, Koeter, G. H., TenVergert, E. M. Costeffectiveness of lung transplantation in relation to type of endstage pulmonary disease. American Journal of Transplantation 4 7 ; : 1155-1162, 2004. Groot, M. de, Schuurs, T. A., Schilfgaarde, R. van. Causes of limited survival of microencapsulated pancreatic islet grafts. Journal of Surgical Research 121 1 ; : 141-150, 2004. Groot, M. de, Haan, B. J. de, Keizer, P. P. M., Schuurs, T. A., Schilfgaarde, R. van, Leuvenink, H. G. D. Rat islet isolation yield and function are donor strain dependent. Laboratory Animals 38 2 ; : 200-206, 2004. Haan, B. J. de, Faas, M. M., Spijker, H., Willigen, J. W. van, Haan, A. de, Vos, P. de. Factors influencing isolation of functional pancreatic rat islets. Pancreas 29 1 ; : E15-E22, 2004. Hartog, J. W. L., Smit, A. J., Son, W. J. van, Navis, G., Gans, R. O. B., Wolffenbuttel, B. H. R., Jong, P. E. de. Advanced glycation end products in kidney transplant patients: A putative role in the development of chronic renal transplant dysfunction. American Journal of Kidney Diseases 43 6 ; : 966-975, 2004. Hene, R. J., Bos, M. A., Slooff, M. J., Kootstra, G. Nieuwe wegen naar orgaandonatie; een advies van de Gezondheidsraad. ['New pathways to organ donation'; a recommendation of the Dutch Health Council]. Nederlands Tijdschrift voor Geneeskunde 148 4 ; : 166-170, 24-1-2004. Heuvel, M. C. van den, Jong, K. P. de, Horst, M. L. C. van der, Poppema, S., Slooff, M. J. H., Gouw, A. S. H. Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree. Liver Transplantation 10 1 ; : 28-35, 2004. Hulzebos, C. V., Bijleveld, C. M. A., Stellaard, F., Kuipers, F., Fidler, V., Slooff, M. J. H., Peeters, S. M. J. G., Sauer, P. J. J and combivent. CARDURA. 22 Carisoprodol . 15 Cartia XT . 10 CASODEX . 24 CATAPRES. 22 Cefuroxime . 7 CELEBREX . 16 CELEXA . 21 CELLCEPT * . 19 CENESTIN . 19 Cephalexin. 7 Chlorthalidone . 10 Chlorzoxazone . 15 Cholestyramine . 10 Cholestyramine light . 10 CIALIS . 19 Cilostazol . 10 Cimetidine . 13 Ciprofloxacin HCL . 7 CIPRO XR . 21 Citalopram HBR . 8 CLARINEX . 25 CLARINEX-D 24 HOUR . 25 clarithromycin . 7 Clidinium - chlordiazepoxide . 13 CLIMARA . 24 Clindamycin HCL . 7 Clobetasol propionate. 12 Clonixine HCL. 10 Clotrimazole . 12 Clotrimazole betamethasone . 12 Colchicine . 8 COLYTE WITH FLAVOR PACKETS . 24 COMBIVENT . 20 COMTAN . 17 CONCERTA . 23 COREG . 18 COSOPT. 25 COUMADIN . 22 COZAAR . 22 CRESTOR . 18 Cyclobenzaprine HCL . 15 CYMBALTA . 21 Cyproheptadine HCL. 12 D DEPAKOTE . DEPAKOTE ER . desonide . Desoximetasone.
Went to the doctor about 3 weeks ago and he gave me clonidine sp and coumadin.
Cause the various constituent parts of the syndrome may be caused by a wide variety of processes that may occur in these very ill patients, including seizures, infection, the effects of drugs, withdrawal from drug therapy, pain, or agitation. PAID signs occur at a time when the patient's mental status is abnormal, and tests such as electroencephalography may be difficult to obtain or coordinate with the intermittent phenomena. These signs invariably include temperature elevation as high as 41C ; , increases in heart and breathing rates, hypertension, diaphoresis, agitation, and extensor posturing. Creatine kinase levels are rarely reported; in one case these values were within the reference range, and in another, elevated. The most commonly used drugs for treatment of PAID are morphine sulfate, bromocriptine mesylate, propranolol hydrochloride, clonidine hydrochloride, lorazepam, and dantrolene sodium. Each one of these drugs is rational and addresses a component of the PAID syndrome Table 2 ; . Opioid receptors are found in brain cardiovascular nuclei, the heart, and blood vessels.20 Opiates such as morphine, when peripherally injected into healthy animals, produce hypotension.21 Morphine induces analgesia, respiratory depression, and bradycardia. Its analgesic properties may interfere with pain as an inciting factor, and its sedative effects may counter the tachycardia and tachypnea. Constipation is a problematic adverse effect of morphine and narcotic dependency. Withdrawal from opiate therapy may provoke signs that falsely suggest PAID. The use of dopamine antagonists or the withdrawal of dopamine agonist therapy may also result in neuroleptic malignant syndrome NMS ; , the clinical features of which suggest PAID. Thus, it is not surprising that the use of bromocriptine, a dopamine agonist, has been found to be helpful in PAID. Because excitation of the sympathetic nervous system appears to be a major feature of PAID, the uses of -adrenergic blockade, such as propranolol nonselective -adrenergic blockade ; or labetalol hydrochloride nonselective - plus 1-adrenergic blockade ; , are logical choices and have proven clinically useful in the amelioration of some of the most important clinical signs eg, hypertension ; , but not cholinergic signs eg, diaphoresis ; of PAID. In the experience of Do et al, 9 1-adrenergic selective antagonists eg, metoprolol or atenolol ; are not effective, as in mitigating autonomic dysregulation. Clonidine, an 2-adrenergic agonist, reduces blood pressure, has a behavior-stabilizing effect, and causes sedation. These features treat the sympathetic signs and may interrupt feedback into the system that otherwise would perpetuate the cycle of autonomic dysregulation. The benzodiazepines, such as lorazepam, have anxiolytic and sedating effects and muscle relaxant properties that may account for benefits observed in treatment of PAID. In addition to its direct muscle relaxant properties, dantrolene may diminish fever due to prolonged muscle contraction and may also reduce the somatosympathetic spinal reflexes that contribute to sympathetic excitation. Provides and additional 45 mg kg day of amoxicillin. Like all P&T Com-mittee authorized therapeutic interchanges, this change will be documented in the Orders and Progress Notes sections of the chart. Esomeprazole is the newest protonpump inhibitor on the market. Protonpump inhibitors have previously been designated therapeutically equivalent by the P&T Committee. This was done before esomeprazole Nexium ; was marketed. Research suggests that 40 mg of esomeprazole is marginally better than lansoprazole 30 mg. Therefore, 30 mg of lansoprazole is the closest equivalent dose for a 20-mg dose of esomeprazole. 40 mg of omeprazole is a reasonable equivalent dose for 20 mg of esomeprazole. Therefore, esomeprazole was designated nonformulary and not available and will be automatically interchanged. Currently, a 20-mg dose of esomeprazole will be changed to 40 mg of pantoprazole tablets or 30 mg of lansoprazole suspension. Famciclovir is a prodrug of penciclovir, which is an antiviral structurally similar to acyclovir. Famciclovir is a frequently requested nonformulary drug that was designated nonformulary and not available. The spectrum of activity of famciclovir is identical to acyclovir. However, famciclovir has a longer half-life and can be given fewer times per day compared with acyclovir. Famciclovir is only available as a tablet and has a labeled indication for the treatment of acute herpes zoster infections, treatment or suppression of recurrent genital herpes in immunocompetent patients, and treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients. Acyclovir and valacyclovir are listed in the Formulary. Acyclovir is available in multiple dosage forms. Valacyclovir is a prodrug of acyclovir. It has a longer half-life than acyclovir and can be given fewer times per day. Valacyclovir is 3- to 7-times more expensive than acyclovir and should be limited to the prevention of herpes infections in bone marrow transplant patients with mucositis. It is being report post-operative hemodynamic changes with clonidine use. Thus, clonidine is a viable alternative for the treatment of post-anesthetic shivering. Magnesium sulfate has been studied at 30-mg kg and 1-gram doses. When administered at shivering onset, both regimens demonstrate good efficacy. Currently, there are no clinical trials comparing magnesium to meperidine. Nalbuphine, a mixed narcotic agonist-antagonist, has also been shown to be an effective anti-shivering agent. A trial comparing nalbuphine and cozaar. To establish, with the use of the selective 2 -antagonist SKF 86466, whether the respiratory effects of clonidine are due to stimulation of 2 -adrenergic receptors. Methods All animal procedures were in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the local ethics committee. Adult male Wistar rats 250300 g body weight ; were anaesthetized with an intraperitoneal injection of 600 mg kg-1 urethane Sigma ; and 120 mg kg-1 -chloralose Fluka AG ; . Supplementary urethane doses were administered i.v. as indicated by response s ; to nociceptive test stimuli. The animals were placed supine recumbency and breathed room air spontaneously. The trachea was exposed in the neck, sectioned below the larynx and cannulated. Catheters were inserted into the femoral vein for drug administration and into the femoral artery for blood pressure monitoring. Rectal temperature was maintained at 38 C with a heating pad. The midcervical segments of the vagi were isolated and prepared for vagotomy prior to measuring studied respiratory variables in neurally intact rats. The carotid region on both sides was dissected under an operating microscope, and carotid sinus nerves CSNs ; were prepared and cut bilaterally at their junctions with glossopharyngeal nerves later during the experiment. The carotid denervation was confirmed by the absence of any response to i.v. injection of 50 g NaCN, which dose elicits a brisk response in rats with intact CSNs. Baroreceptor denervation was completed when no hypertensive response occurred on clamping both common carotid arteries. Tidal volume. We may be unable to maintain our proposed schedules for investigational new drug applications, which are regulatory filings made by a drug sponsor to the fda to allow human clinical testing in the united states, and equivalent foreign applications and clinical protocol submissions to the fda and other regulatory agencies and cyclobenzaprine. Closely monitor patients receiving MAO inhibitors or catecholamine-depleting drugs such as reserpine or guanethidine ; . The added -adrenergic-blockade of metoprolol may excessively reduce sympathetic activity. LOPRESOR should not be combined with other -blockers. Prazosin selective alpha-1-adrenergic antagonist ; The acute postural hypotension that can follow the first dose of prazosin may be increased in patients already taking a beta-blocker CYP2D6 inhibitors Potent inhibitors of this enzyme may increase the plasma concentration of metoprolol. Strong inhibition of CYP2D6 would result in the change of phenotype into poor metabolizer. Caution should therefore be exercised when co-administering potent CYP2D6 inhibitors with metoprolol. Known clinically significant potent inhibitors of CYP2D6 are antidepressants such as fluoxetine, paroxetine or bupropion, antipsychotics such as thioridazine, antiarrhythmics such as quinidine or propafenone, antiretrovirals such as ritonavir, antihistamines such as diphenhydramine, antimalarials such as hydroxychloroquine or quinine, antifungals such as terbinafine and medications for stomach ulcers such as cimetidine or ranitidine. The following medicinal products concentrations of metoprolol Digitalis glycosides Concurrent use of digitalis glycosides may result in excessive bradycardia and or increase in atrioventricular conduction time. -Adrenergic stimulants cold remedies, nasal drops ; Exaggerated hypertensive responses can be produced when -blockers are combined with -adrenergic agonists. NSAIDs Concurrent treatment with indomethacin may decrease the antihypertensive effect of blockers. Hepatic Enzyme-Inducers Hepatic enzyme-inducing substances may exert an influence on the plasma level of metoprolol. The plasma concentration of metoprolol is lowered by rifampicin. Effect of metoprolol on other medicinal products Clonidkne Withdrawal Syndrome may decrease the effect or plasma. Dementia: Can it be prevented? Table 4 Activities found to be protective Walking for pleasure or excursion Physical conditioning Going to cinema, restaurants and sporting venues Community volunteer work Going to a club or centres Going to church synagogue temple Visiting friends and relatives and depakote.

Fertility of male or female rats was unaffected by clonidine hcl doses as high as 150 g kg or about 3 times the maximum recommended daily human dose mrdhd. Zine infusion were in marked contrast to the low renal excretory levels of water and sodium observed in rats anesthetized with ketamine or pentobarbital alone 7 ; . Similar to these findings, a number of studies have shown that other 2-agonists e.g., clonidine, guanabenz, BHT-933, rilmenidine, etc. ; also produce a diuretic and natriuretic response in anesthetized and conscious ; animals and humans 13, 17, 18, ; . Despite these findings, the mechanisms by which these compounds change the renal excretion of water and sodium have not been completely elucidated. Reduced renal excretory responses occur in surgically operated animals and humans anesthetized with different anesthetic agents 4, 10, 32, ; . Because surgery and anesthesia are potent stimuli for vasopressin release, 2-agonists may produce diuretic and natriuretic responses during anesthesia and surgery by inhibiting the central nervous system CNS ; secretion and or renal tubular action s ; of vasopressin. In regard to this latter possibility, considerable evidence indicates that the activation of renal 2-adrenoceptors is a predominant mechanism by which selective 2-agonists produce diuretic and natriuretic responses in several mammalian species 14, 15, 40, ; . Stimulation of renal 2-adrenoceptors inhibits vasopressin-mediated cAMP formation and the subsequent effects on water and sodium excretion 27, 28, 40 ; . Based on these findings, the intravenous infusion of xylazine may enhance renal excretory function in ketamine-anesthetized rats by stimulating 2-adrenoceptors in the collecting duct and thus modulating the antidiuretic effect of vasopressin in this nephron segment. In addition to a direct renal action, it is possible that a portion of the diuretic and or natriuretic response elicited by the intravenous infusion of xylazine in ketamine-anesthetized rats is mediated by a pathway involving 2-adrenoceptors located in the CNS. More specifically, the increase in urine flow rate produced by intravenous xylazine may result, at least in part, from a central action of the drug to inhibit the secretion of vasopressin. Such a mechanism would be consistent with the results of a number of studies showing that the activation of central adrenergic receptors, in particular the 2-receptor subtype, inhibits the release of vasopressin in conscious and anesthetized animals 6, 20, 21, ; . Although changes in circulating vasopressin levels may also contribute, it appears that the natriuretic response produced by 2-adrenoceptor agonists is mediated by an alternative mechanism s ; independent of this hormone 3, 9, 22, The purpose of the present study was to examine the contribution of central 2-adrenergic receptor mechanisms in mediating the enhanced renal excretory responses produced by the intravenous infusion of xylazine in ketamine-anesthetized rats. For this purpose, we compared the changes in renal function produced by the intravenous and intracerebroventricular injection of the 2-adrenergic receptor antagonist yohimbine in ketamine- and xylazine-anesthetized rats. Microinjection techniques were then used to determine whether 2-adrenoceptors in the hypothalamic paraventricular nucleus PVN ; play a role in mediating the enhanced renal responses to xylazine. The PVN was chosen as the focus of these studies because the PVN contains neurons that synthesize and release vasopressin in the posterior pituitary 44 ; . Vasopressin secretion is known to be markedly enhanced under conditions of anesthesia and surgery 8, 11, 30, ; . In addition, the vasopressinergic neurons in the PVN receive dense catecholaminergic projections from the A1 and other nuclei 44 ; and contain large numbers of 2-adrenoceptors 1, 34, Subjects Experiments were performed using male Sprague-Dawley rats 275325 g, Harlan ; . All procedures were done in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Care and Use Committee at Louisiana State University Medical Center. The rats were housed in groups in a temperature- and humidity-controlled room with a 12: 12-h light-dark cycle. Standard rat chow Na content 163 meq kg ; and tap water were available ad libitum. Surgical Procedures Intracerebroventricular cannula implantation. Five to seven days before the experiment certain rats were anesthetized ketamine 30 mg kg im in combination with xylazine 3 mg kg im ; and a stainless steel cannula was implanted into the right lateral cerebral ventricle. The cannula was implanted 0.3 mm posterior to the bregma, 1.3 mm lateral to the midline, and 4.5 mm below the skull surface 36 ; . The cannula was fixed into position by using jewelers' screws and cranioplastic cement. Verification of the cannula position in the lateral ventricle was made by observing the leakage of cerebrospinal fluid from the cannula after removal of the obturator 7 ; . Catheter implantation. On the day of the experiment rats were anesthetized with sodium methohexital Brevital, 35 mg kg ip, supplemented with 10 mg kg iv as needed; Lilly, Indianapolis, IN ; . Catheters PE-50 fused to PE-10 ; were placed in the femoral artery and vein for the recording of arterial pressure and administration of drugs, respectively. The catheters were tunneled subcutaneously to the back of the neck, flushed, and plugged. A suprapubic incision was then made, and a bladder catheter flanged PE-240 ; was inserted and sutured into the urinary bladder. The bladder catheter was then exteriorized and secured by suturing it to adjacent muscle and skin. After surgical preparation, the rat was placed in a rat holder, which permitted the collection of urine. Rats then received ketamine 40 mg kg iv ; over a 5-min period. A supplemental intravenous infusion 55 l min ; of isotonic saline containing ketamine 1.0 mg kg 1 min 1 ; and xylazine 50 g kg min 1 ; was then started and continued and detrol.
Figure 2. Insertion sequence IS ; 6110 Southern blot hybridization patterns for major multidrug-resistant Mycobacterium tuberculosis strains, New York City, 19951997. STD, standard, because clonidine hcl side effects. Abstract We have examined the interactions, in eliciting CAMP accumulation, between vasoactive intestinal polypeptide VIP ; and the three monoamines norepinephrine NE ; , histamine HIS ; , and serotonin 5-hydroxytryptamine, 5-HT ; in mouse cerebral cortical slices. We have observed that NE and HIS, but not 5-HT, act synergistically with VIP to increase CAMP levels. The rank-order of potency of several adrenergic agonists in potentiating the effect of VIP on CAMP levels is the following: epinephrine NE phenylephrine clonidine, with EC , of 2.2, 5, and 10 PM, respectively clonidine being only marginally effective ; . This pharmacological profile is characteristic of the activation of a, -adrenergic receptors. This contention is substantiated by the observation that the potentiating effect of NE is antagonized by the selective n, -adrenergic antagonist prazosin at nanomolar concentrations. The potentiating effect of HIS is mediated by H, -histaminergic receptors since it is antagonized by the selective HI-receptor antagonist mepyramine but not by cimetidine, a selective HZ-receptor antagonist. The synergistic interaction between VIP and NE is also observed in the presence of the adenosine antagonist theophylline, thus discarding the possibility of a mediation of the synergism by adenosine released by VIP. In view of the morphological and physiological properties of the VIP intracortical neuronal system and the noradrenergic projection to the cerebral cortex, it appears that sensory stimulation may constitute a behavioral event whereby the synergism between VIP and NE may become operative and lead to a drastic increase in the levels of CAMP within a discrete cortical volume delineated by the intersection of the tangentially organized noradrenergic fibers and a group of activated, radially oriented VIP intracortical neurons and diazepam. The members of the two advisory committees concerned psychopharmacologic drugs and paediatric advisory committee ; concluded that the finding of an increased risk of suicidality in clinical trials was a group effect and recommended that any warning related to an increased risk should be applied to all antidepressant drugs studied or not and a patient information should be provided to children and their caregivers with every prescription They reached a split decision 15 yes 8 no ; recommending a so called black box warning but were unanimous that these drugs should not be contraindicated because the access to these therapies was important for those who could benefit. The controversy on the pros and cons of a black box warning was made public by the N ENG J Med asking to committee members to comment [11], [10], [2].

Dopamine and noradrenaline in exploratory behaviour 48 by d-amphetamine and apomorphine in the rat. Psychopharmacology 96, 521-527. Di Lullo, S. L., Martin-Iverson, M. T., 1991. Presynaptic dopaminergic neurotransmission mediates amphetamine-induced unconditioned but not amphetamine-conditioned locomotion and defecation in the rat. Brain Research 568, 45-54. Exner M., Clark D., 1993. Behaviour in the novel environment predicts responsiveness to d-amphetamine in the rat: a multivariate approach. Behavioral Pharmacology 4, 47-56. Feifel, D., Priebe, K., Shilling, P.D., 2001. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology 24, 663-70. Foote, S.L., Bloom, F.E., Aston-Jones, G., 1983. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiological Reviews 63, 844-914. Gerra G., Zaimovic A., Ferri M., Zambelli U., Timpano M., Neri E., Marzocchi G.F., Delsignore R., Brambilla F., 2000. Long-lasting effects of + - ; 3, 4methylenedioxymethamphetamine ecstasy ; on serotonergic system function in humans. Biological Psychiatry 47, 127-136. Gesi, M., Soldani, P., Giorgi, F.S., Santinami, A., Bonaccorsi, I., Fornai, F., 2000. The role of the locus coeruleus in the development of Parkinson's disease. Neuroscience and Biobehavioral Reviews 24, 655-668. Grenhoff, J., Nisell, M., Ferre, S., Aston-Jones, G., Svensson, T. H., 1993. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. Journal of Neural Transmission. General Section 93, 11-25. Grenhoff, J., Svensson, T. H. 1989. Clonidine modulates dopamine cell firing in rat ventral tegmental area. European Journal of Pharmacology 165, 11-18. Hidkind, R., Kivastik, T., Eller, M., Kolts, I., Oreland, L., Harro, J., 2002. Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP4 [N 2-chloroethyl ; -N-ethyl-2-bromobenzylamine] reduces dopamine release potential in the nucleus accumbens shell in conscious rats. Neuroscience Letters 332, 79-82. Harro, J., 1993. Measurement of exploratory behavior in rodents. Methods in Neuroscience 14, 359-377. Mean 5.78 ; . Dissolved oxygen was low in most streams during the summer, concentrations less than 5 mg L were detected at all streams. Dissolved oxygen was generally higher during the summer 1999 than in 1998 1997. Of the surface waters, nutrient levels were highest in spring and summer and typically highest at Taylor Branch and Marumsco Creek. Ammonia concentration exceeded 0.7 mg L at Kings Creek, Taylor Branch and Marumsco Creek. Nitrate concentrations in surface waters ranged from not detected to 3.0 mg L. Nitrate exceeding 2.0 mg L was observed in all creeks except Manokin, Rehobeth and Kings creeks. Nitrate was consistently high at the Westover well where up to 15.0 mg L was detected which exceeded the upper limit for drinking water. High phosphate concentrations 1.0 mg L ; were detected in all creeks except Somerset, Manokin and Rehobeth Creeks. Scope of Work This report contains results obtained during the 1999 water quality survey in Somerset County along with an summary of the results obtained during the 1997 and 1998 surveys and reported in Jesien 1997, 1998 ; . Nine locations were visited approximately monthly from October 1998 through September 1999 and monitored for physical and chemical water quality parameters, including temperature, dissolved oxygen, conductivity, pH and nutrients. Nutrients included ammonia, nitrate and phosphate. Station locations were selected to provide wide coverage of freshwater areas within the county. Monitoring Site Descriptions Creeks from all the major drainages in the county, i.e., Wicomico River, Manokin River and Pocomoke River watersheds, were sampled Table 1, Figure 1 ; . One station was located within the Wicomico River watershed, Somerset Creek in the northern part of the county. Four stations were located within the Manokin River watershed, Manokin Creek, Manokin River, Kings Creek and Taylor Branch which are in the mid portion of the county. Three stations were located within the Pocomoke River watershed, two on Marumsco Creek and one on Rehobeth Creek. A spring located near the mid portion of the county was sampled because it is commonly used for drinking water. Station 1 on Somerset Creek is located upstream of the bridge at Rt 529 Table 1 ; . The watershed above the sampling station is generally wooded. A large stand of bamboo occurs downstream of the bridge and a gravel mine is operating upstream of the sampling site. Four stations were established within the Manokin River watershed, Manokin Creek, Station 2, Kings Creek, Station 3, Taylor Branch, Station 4 and Manokin River, Station 7. The creeks have been channelized and drain areas that are intensively used for agriculture. For the 1999 survey, a new station was established further up river than the station at Raccoon Point. The new station was established along the Manokin River in the Hayman's Purchase Community off Stewart Neck Road. The station is located at Mr. A. We report the novel finding that GnRH stimulates SF-l gene expression, which is the first delineation of a factor involved in the regulation of this nuclear receptor. SF-l mRNA increased in both male and female GDX rats, an effect that was prevented by the administration of T. Since continuous T replacement has been shown to inhibit GnRH secretion 8, 1 l ; , it likely that the SF-l mRNA increase in GDX animals reflects the rise in GnRH release due to the loss of steroid feedback. Furthermore, male T concentrations reduced SF-l mRNA to levels below those seen in intact animals. This finding may imply a direct pituitary action of T on SF-l expression, or reflect the fact that the animals were GnRH-deficient as suggested by undetectable serum LH levels ; . However, the smaller SF-l mRNA response to exogenous GnRH pulses in the presence of female levels of T Fig 3 ; , suggests thatT may exert direct inhibitory actions on pituitary SF-l expression. Of interest, the magnitude of the rise in SF-l to 6h of pulsatile GnRH was lower than that seen 7 days post-OVX 64% vs 100% increases vs controls, respectively ; . Whether this difference in response to GnRH simply reflects duration of stimulation, or the effect of other.

The body also needs calcium to carry nerve signals, keep the heart functioning, contract muscles, clot blood and maintain healthy skin!